Bertrand Dubois

机构：Lyon 1 Université, Centre National de la Recherche Scientifique, Inserm, Centre de Recherche en Cancérologie de Lyon · ORCID：0000-0002-7859-4975

发表论文 252 篇 · 总被引 9571 次 · h-index 43

代表论文

• Tumor–stroma proportion on primary tumor as a prognostic biomarker in advanced ovarian cancer patients receiving chemo-immunotherapy as first-line therapy: analyses from the NeoPembrOV/GINECO phase II randomized trial (2025 · ESMO Open · 被引 6)
• Neoadjuvant immune checkpoint blockade before chemoradiation for cervical squamous carcinoma (GINECO window-of-opportunity COLIBRI study): a phase II trial (2026 · Nature Communications · 被引 4)
• Immune landscape and TAM density in endometrial cancer: implications for immune checkpoint inhibitors efficacy (2025 · Therapeutic Advances in Medical Oncology · 被引 4)
• Unraveling the Tumor Microenvironment and PD-L1 Expression across Tissue Types in High-Grade Serous Ovarian Cancer in the NeoPembrOV/GINECO Phase II Randomized Trial (2025 · Clinical Cancer Research · 被引 4)
• Breast Cancer Specificities of Patients With Anti-Ri Paraneoplastic Neurologic Syndromes (2025 · Neurology Neuroimmunology & Neuroinflammation · 被引 3)
• Spatial tumour-immune ecosystems shape the efficacy of anti-PD1 immunotherapy in primary cutaneous melanoma (2025 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 2)